CY1116335T1 - PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDEInfo
- Publication number
- CY1116335T1 CY1116335T1 CY20151100301T CY151100301T CY1116335T1 CY 1116335 T1 CY1116335 T1 CY 1116335T1 CY 20151100301 T CY20151100301 T CY 20151100301T CY 151100301 T CY151100301 T CY 151100301T CY 1116335 T1 CY1116335 T1 CY 1116335T1
- Authority
- CY
- Cyprus
- Prior art keywords
- chloropyridin
- yloxy
- carboxamide
- ethoxy
- amino
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Αποκαλύπτονται άλατα και κρυσταλλικές μορφές του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου και των αλάτων εξ αυτού. Επίσης αποκαλύπτονται μια τουλάχιστον φαρμακευτική σύνθεση που περιλαμβάνει μια τουλάχιστον κρυσταλλική μορφή του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου, μια τουλάχιστον μέθοδος χρήσης μιας τουλάχιστον κρυσταλλικής μορφής του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου για την αγωγή του καρκίνου και/ή άλλων υπερπλαστικών παθήσεων, και διεργασίες για την παρασκευή των κρυσταλλικών μορφών του Ν-(4-(2-αμινο-3-χλωροπυριδιν-4-υλοξυ)-3-φθοροφαινυλ)-4-αιθοξυ-1-(4-φθοροφαινυλ)-2-οξο-1,2-διϋδροπυριδιν-3-καρβοξαμιδίου και των αλάτων εξ αυτού.Salts and crystalline forms of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2-oxo-1,2- dihydropyridine-3-carboxamide and the salts thereof. Also disclosed are at least one pharmaceutical composition comprising at least one crystalline form of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2 -oxo-1,2-dihydropyridin-3-carboxamide, at least one method of using at least one crystalline form of N- (4- (2-amino-3-chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy- 1- (4-fluorophenyl) -2-oxo-1,2-dihydropyridin-3-carboxamide for the treatment of cancer and / or other hyperplastic diseases, and processes for the preparation of crystalline forms of N- (4- (2- amino-3 -chloropyridin-4-yloxy) -3-fluorophenyl) -4-ethoxy-1- (4-fluorophenyl) -2-oxo-1,2-dihydropyridin-3-carboxamide and the salts thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32971010A | 2010-04-30 | 2010-04-30 | |
| EP11717917.6A EP2563763B1 (en) | 2010-04-30 | 2011-04-29 | Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1116335T1 true CY1116335T1 (en) | 2017-02-08 |
Family
ID=58457985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20151100301T CY1116335T1 (en) | 2010-04-30 | 2015-03-26 | PHARMACEUTICAL COMPOSITIONS CONTAINING N- (4 (2-AMINO-3-CHLOROPYRIDIN-4-YLOXY) -3-FLUOROPHYNYL) -4-ETHOXY-L-(4-FYTHO-2-O -YYYL) -CARBOXAMIDE |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1116335T1 (en) |
-
2015
- 2015-03-26 CY CY20151100301T patent/CY1116335T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125613T1 (en) | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4- IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK INHIBITORS | |
| CY1121418T1 (en) | HEPATITIS VIRUS INHIBITORS C | |
| CY1123810T1 (en) | TRIFLUOROMETHYL SUBSTITUTED PYRAZOLES AS KALLIKREIN INHIBITORS IN HUMAN PLASMA | |
| CY1120318T1 (en) | Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperplasia patients | |
| CY1123627T1 (en) | DIHYDROIMIDAZOPYZINONE DERIVATIVES USEFUL IN THE THERAPEUTIC TREATMENT OF CANCER | |
| CY1121625T1 (en) | PRMT5 INHIBITORS AND USES THEREOF | |
| CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
| EA201490647A1 (en) | DERIVATIVES OF BENZOTHIAZOL-6-LUCUS ACID AND THEIR APPLICATION FOR THE TREATMENT OF HIV INFECTION | |
| CY1119004T1 (en) | DIAHYDROPYRIDONE P1 AS AN OPTIONAL CHIA | |
| CY1118135T1 (en) | DERIVATIVE 2- (PAINYL OR PYRID-3-YL) AMINOPYRIMIDINE AS LRRK2 MODIFYING REGULATORS FOR THERAPEUTIC DISEASE TREATMENT | |
| MX2015013396A (en) | Quinolines derivatives as novel anticancer agents. | |
| EA201500298A1 (en) | ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES | |
| MX2024009886A (en) | QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS. | |
| PH12019501896A1 (en) | Therapeutic dendrimers | |
| CY1123494T1 (en) | ETEPOAPYLO-KAPBOXAMIDIOY COMPOUNDS AS THS RIPK2 ANASTOLES | |
| BR112014007163A2 (en) | n-methyl-2 [3 ((e) -2-pyridin-2-yl-vinyl) -1h-indazol-6-ylsulfanyl] -benzamide pharmaceutical compositions | |
| CY1114140T1 (en) | 4-PYRIDINONE COMPONENTS AND THEIR USE FOR CANCER | |
| MX2013008431A (en) | Mineralocorticoid receptor antagonists. | |
| CY1124251T1 (en) | CARBOXAMIDE DERIVATIVES | |
| EA201300946A1 (en) | ASYMMETRIC UREA AND THEIR MEDICAL APPLICATION | |
| CY1116775T1 (en) | Pyrimidone derivatives as inhibitors of viral transglutaminase | |
| TW201613864A (en) | Novel compounds | |
| WO2013040227A3 (en) | Therapeutic compounds | |
| EA201600122A1 (en) | NEW ISOINDOLINE OR ISOHINOLINE COMPOUNDS, METHOD FOR PRODUCING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| CY1121063T1 (en) | INHIBITORS OF ALDOSTERONE COMPOSITION |